MET

EIKCS 2021: Biomarkers for kidney cancer

By Robert|2021-07-07T11:44:37+00:0026 Apr 2021|Drug treatments|

Dr Thomas Powles from St Barts Hospital, London spoke about [...]

Comments Off

ASCO GU 2021: Comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for advanced papillary kidney cancer

By Sharon Kell|2021-02-15T10:03:32+00:0015 Feb 2021|Drug treatments|

A gene called MET codes for a protein called MET [...]

Comments Off

Savolitinib shows promise in first-in-human phase 1 study in solid tumours

By Sharon Kell|2019-05-07T13:50:24+00:007 May 2019|Drug treatments|

Results from a first-in-human phase 1 study of savolitinib in [...]

Comments Off

Current treatment of advanced papillary renal cell carcinoma

By Sharon Kell|2017-07-26T07:43:03+00:0026 Jul 2017|Drug treatments|

Despite significant improvements in the treatment outcomes of clear cell [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Follow

Web Design by Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org